drugset / Trial / NCT02245269

Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers

NCT02245269

Phase 1 Completed 23 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

Study to determine the effects of combined tipranavir and ritonavir treatment (at steady-state) on the single-dose pharmacokinetics of atorvastatin, the effects of single-dose atorvastatin on the steady-state pharmacokinetics of tipranavir, and the effects of antacid on the pharmacokinetics of tipranavir

Timeline

Start
2003-07
Primary completion
2003-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule
Subject Maalox Unknown
Subject Tipranavir Small molecule 500 mg
Background Ritonavir Other / unclassified 200 mg

Indications

No indication recorded.